arrow
S

Seth J. Baum

merck & company
H指数:42
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Olezarsen reduces all-cause health services utilization and improves the treatment experience of patients with familial chylomicronemia syndrome

Olezarsen降低了家族性乳糜微粒血症综合征患者的全因医疗资源使用,并改善了其治疗体验。

2025-12-190
PREAI
Patient Experience With Familial Chylomicronemia Syndrome Before and After Olezarsen Treatment: Qualitative Interviews With Clinical Trial Participants

家族性乳糜微粒血症综合征患者在奥莱萨森治疗前后对疾病体验的质性访谈:基于临床试验参与者的研究报告

2025-06-180
OAAI
Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers Results From the OCEAN(a)-DOSE Trial

Olpasiran、氧化磷脂和系统性炎症生物标志物结果:来自OCEAN(a)-DOSE试验

2025-02-122
PRE
Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial

替热帕德对射血分数保留和肥胖的心力衰竭患者循环超负荷和终末器官损害的影响: SUMMIT试验的二次分析

2024-11-170
OAAI